Trials / Completed
CompletedNCT04750304
Evaluation of the Use of an E-health Therapeutic Education Application for Osteoarthritis Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Osteoarthritis is the most common joint disease affecting the joint in a comprehensive and progressive manner. It leads to increasing disability. The recommendations of recent years favor the non-pharmacological treatment of osteoarthritis including regular physical activity, therapeutic education and weight loss Osteoarthritis population has a low level of physical activity due to a lack of information, motivation and false beliefs related to physical activity and kinesiophobia (fear of movement) A preliminary qualitative study (ARTHe1) evaluating the barriers and levers of the use of an e-health therapeutic education application in patients with osteoarthritis was carried out in order to guide the development of the ARTHe application. The objective of this study is to have the application tested on a panel of patients in order to assess the benefits of using the application in terms of adherence to the practice of physical activity but also in clinical terms on function and pain, and the satisfaction of the patient
Detailed description
This is a prospective observational study including the evaluation of the use of the ARTH-e application after 3 weeks, 6 weeks and 3 months of use. Patient recruitment will be done in the PRM department of Clermont-Ferrand University Hospital A subgroup of patients will receive a Garmin VivoSmart 4 connected wristband, which will record intrinsic stress measurement data during the test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Application ARTHe | Patient will use ARTHe Application for 3 months |
Timeline
- Start date
- 2022-01-31
- Primary completion
- 2022-07-07
- Completion
- 2022-07-07
- First posted
- 2021-02-11
- Last updated
- 2022-07-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04750304. Inclusion in this directory is not an endorsement.